These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19422283)

  • 1. Cell death pathways in Parkinson's disease: role of mitochondria.
    Yao Z; Wood NW
    Antioxid Redox Signal; 2009 Sep; 11(9):2135-49. PubMed ID: 19422283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.
    Ryan BJ; Hoek S; Fon EA; Wade-Martins R
    Trends Biochem Sci; 2015 Apr; 40(4):200-10. PubMed ID: 25757399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease.
    Lin TK; Liou CW; Chen SD; Chuang YC; Tiao MM; Wang PW; Chen JB; Chuang JH
    Chang Gung Med J; 2009; 32(6):589-99. PubMed ID: 20035637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?
    Bogaerts V; Theuns J; van Broeckhoven C
    Genes Brain Behav; 2008 Mar; 7(2):129-51. PubMed ID: 17680806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Mani S; Sevanan M; Krishnamoorthy A; Sekar S
    Neurol Sci; 2021 Nov; 42(11):4459-4469. PubMed ID: 34480241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic animal models of Parkinson's disease.
    Dawson TM; Ko HS; Dawson VL
    Neuron; 2010 Jun; 66(5):646-61. PubMed ID: 20547124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO-regulated mitochondrial function in Parkinson's disease.
    Guerra de Souza AC; Prediger RD; Cimarosti H
    J Neurochem; 2016 Jun; 137(5):673-86. PubMed ID: 26932327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parkin and mitochondria].
    Mitsui T; Kuroda Y; Kaji R
    Brain Nerve; 2008 Aug; 60(8):923-9. PubMed ID: 18717196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of Parkinson's disease.
    Sherer TB; Betarbet R; Greenamyre JT
    Curr Opin Investig Drugs; 2001 May; 2(5):657-62. PubMed ID: 11569943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemistry changes associated with mutations in familial Parkinson's disease.
    Siddique MM; Tan EK
    Curr Med Chem; 2010; 17(35):4378-91. PubMed ID: 20939808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2012 Nov; 53(9):1791-806. PubMed ID: 22967820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PINK1 protein in normal human brain and Parkinson's disease.
    Gandhi S; Muqit MM; Stanyer L; Healy DG; Abou-Sleiman PM; Hargreaves I; Heales S; Ganguly M; Parsons L; Lees AJ; Latchman DS; Holton JL; Wood NW; Revesz T
    Brain; 2006 Jul; 129(Pt 7):1720-31. PubMed ID: 16702191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.
    Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
    Eur J Neurosci; 2021 May; 53(9):2946-2959. PubMed ID: 32031280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
    Dodson MW; Guo M
    Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.